FDA approves Pfizer-BioNTech LP.8.1-adapted monovalent COVID-19 vaccine for high-risk groups Read more
Eli Lilly announces Phase 3 ATTAIN-2 trial results for oral GLP-1 agonist orforglipron in obesity and type 2 diabetes Read more
Novartis and BioArctic sign collaboration agreement on BrainTransporter technology for neurological drug development Read more
Industry expert calls for GST parity to support MSMEs and strengthen India’s position as the ‘Pharmacy of the World’ Read more